Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Shares of Kura Oncology, Inc. (NASDAQ:KURA – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the twelve brokerages that are covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to […]
More Stories
Udemy (NASDAQ:UDMY) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Udemy (NASDAQ:UDMY – Free Report) from a buy rating to a strong-buy rating in...
Siebert Financial (NASDAQ:SIEB) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Siebert Financial (NASDAQ:SIEB – Free Report) to a buy rating in a research report...
United Airlines (NASDAQ:UAL) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of United Airlines (NASDAQ:UAL – Free Report) from a buy rating to a strong-buy rating...
Brokerages Set Champion Iron Limited (TSE:CIA) PT at C$7.06
Shares of Champion Iron Limited (TSE:CIA – Get Free Report) have earned a consensus recommendation of “Buy” from the five...
BlackRock TCP Capital (NASDAQ:TCPC) Cut to Hold at Wall Street Zen
Wall Street Zen downgraded shares of BlackRock TCP Capital (NASDAQ:TCPC – Free Report) from a buy rating to a hold...
Head-To-Head Survey: Zeo Energy (NASDAQ:ZEO) vs. Electrovaya (NASDAQ:ELVA)
Zeo Energy (NASDAQ:ZEO – Get Free Report) and Electrovaya (NASDAQ:ELVA – Get Free Report) are both small-cap energy companies, but...